146 related articles for article (PubMed ID: 9044517)
1. Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions.
Renganathan R; Suranjan B; Kurien T
Spinal Cord; 1997 Feb; 35(2):99-103. PubMed ID: 9044517
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured.
Sønksen J; Biering-Sørensen F
Paraplegia; 1992 Aug; 30(8):554-7. PubMed ID: 1522996
[TBL] [Abstract][Full Text] [Related]
3. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
[TBL] [Abstract][Full Text] [Related]
4. [Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
Lebib Ben Achour S; Laffont I; Boyer F; Boiteau F; Dizien O
Ann Readapt Med Phys; 2001 Feb; 44(1):35-40. PubMed ID: 11587653
[TBL] [Abstract][Full Text] [Related]
5. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
[TBL] [Abstract][Full Text] [Related]
6. Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Chochina L; Naudet F; Chéhensse C; Manunta A; Damphousse M; Bonan I; Giuliano F
Sex Med Rev; 2016 Jul; 4(3):257-269. PubMed ID: 27871959
[TBL] [Abstract][Full Text] [Related]
7. Intracavernous papaverine for impotence in spinal cord injured patients.
Kapoor VK; Chahal AS; Jyoti SP; Mundkur YJ; Kotwal SV; Mehta VK
Paraplegia; 1993 Oct; 31(10):675-7. PubMed ID: 8259331
[TBL] [Abstract][Full Text] [Related]
8. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
Tang SF; Chu NK; Wong MK
Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
[TBL] [Abstract][Full Text] [Related]
9. [Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries].
Sønksen JO; Hansen EF; Biering-Sørensen F; Colstrup H
Ugeskr Laeger; 1990 Oct; 152(41):3006-9. PubMed ID: 2238171
[TBL] [Abstract][Full Text] [Related]
10. [Erectile dysfunction of male spinal cord injury patients].
Schurch B; Kuhn W
Schweiz Rundsch Med Prax; 1990 Sep; 79(38):1085-8. PubMed ID: 2218240
[TBL] [Abstract][Full Text] [Related]
11. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H
J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
Chancellor MB; Rivas DA; Panzer DE; Freedman MK; Staas WE
Urology; 1994 Mar; 43(3):365-9. PubMed ID: 8134992
[TBL] [Abstract][Full Text] [Related]
13. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
[TBL] [Abstract][Full Text] [Related]
14. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure.
Virag R; Frydman D; Legman M; Virag H
Angiology; 1984 Feb; 35(2):79-87. PubMed ID: 6696289
[TBL] [Abstract][Full Text] [Related]
15. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
16. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
[TBL] [Abstract][Full Text] [Related]
17. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
Ghanem H; Sherif T; Adbel-Gawad T; Asaad T
Int J Impot Res; 1998 Dec; 10(4):211-4. PubMed ID: 9884916
[TBL] [Abstract][Full Text] [Related]
18. Comments from Ronald Virag on intracavernous injection: 25 years later.
Virag R
J Sex Med; 2005 May; 2(3):289-90. PubMed ID: 16422859
[No Abstract] [Full Text] [Related]
19. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
Lloyd LK; Richards JS
Paraplegia; 1989 Dec; 27(6):457-64. PubMed ID: 2608299
[TBL] [Abstract][Full Text] [Related]
20. The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.
Earle CM; Keogh EJ; Ker JK; Cherry DJ; Tulloch AG; Lord DJ
Paraplegia; 1992 Apr; 30(4):273-6. PubMed ID: 1625897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
